"Designing Growth Strategies is in our DNA"

DNA Synthesis Market Size, Share & Industry Analysis, By Product & Service (Products {Instruments, Reagents & Consumables}, and Services), By Type (Oligonucleotide Synthesis & Gene Synthesis), By Application (Diagnostics {Infectious Diseases, Cancer}, Therapeutics {Gene Therapy, Preventive Medicine, and Research & Development {Cloning and Gene Editing, Drug Discovery & Development}), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Development And Manufacturing Organizations), & Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI109799

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Unit

Value (USD billion)

Growth Rate

CAGR of 17.1% from 2024-2032

Segmentation

By  Product & Service

  • Products
    • Instruments
    • Reagents & Consumables
  • Services

By Type

  • Oligonucleotide Synthesis
  • Gene Synthesis

By Application

  • Diagnostics
    • Infectious Diseases
    • Cancer
    • Others
  • Therapeutics
    • Gene Therapy
    • Preventive Medicine
    • Others
  • Research & Development
    • Cloning and Gene Editing
    • Drug Discovery & Development
    • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
  • Others

By Region

  • North America (By Product & Service, By Type,  By Application,  By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By  Product & Service, By Type,  By Application,  By End-user, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By  Product & Service, By Type,  By Application,  By End-user, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By  Product & Service, By Type,  By Application,  By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By  Product & Service, By Type,  By Application,  By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • 2019-2032
  • 2023
  • 2019-2022
  • 183
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann